Kyntra Bio KYNB Cash Flow Statement (2014-2026)

NASDAQ KYNB
$7.32 +0.17 (+2.38%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
49.46M-134.42M-63.52M-73.19M-92.06M-66.45M-77.50M-88.23M-64.29M-92.95M16.11M31.55M31.21M26.65M21.41M6.08M213.78M0.39M-0.07M
Depreciation and Depletion (Quarter)
2.48M2.45M2.45M2.52M2.54M2.50M2.54M2.48M2.63M1.86M0.81M0.77M0.73M0.34M0.32M0.21M0.18M
Share-based Compensation (Quarter)
15.70M-46.72M17.15M16.66M-29.25M61.04M32.00M-32.00M0.24M0.15M0.08M0.11M0.01M2.85M-2.80M5.34M-5.32M1.15M0.98M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
1.00M
Cash from Operations (Quarter)
44.26M-54.96M-8.48M-33.06M-51.88M-52.51M-101.59M-110.57M-84.54M-18.32M-59.29M-39.87M-8.38M-30.47M2.72M12.68M-1.85M-18.33M-13.89M-3.99M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.12M0.13M-0.93M-0.58M-0.33M2.43M0.69M1.13M-1.41M0.01M0.01M1.67M-1.65M0.01M0.00M0.02M-0.02M0.07M0.18M0.10M
Depreciation & Amortization (CF) (Quarter)
2.48M2.45M2.45M2.52M2.54M2.50M2.54M2.48M2.63M1.86M0.81M0.77M0.73M0.34M0.32M0.21M0.18M
Change in Working Capital
Change in Receivables (Quarter)
11.74M-19.05M26.48M-10.28M-17.18M0.22M1.30M8.71M6.28M-19.72M24.68M-30.65M21.92M-9.22M3.16M-0.16M-0.55M0.09M4.82M-4.69M
Change in Inventory (Quarter)
4.80M1.50M12.00M-1.14M0.29M-0.15M1.94M0.01M-0.43M0.18M-13.79M-1.79M-2.20M-4.51M-2.86M-1.35M-1.03M-0.12M-0.36M
Change in Account Payables (Quarter)
-0.10M1.92M10.21M-6.01M-9.31M11.03M40.47M-61.26M6.73M-1.46M-13.59M5.61M-0.73M23.22M-24.77M3.07M-4.61M-1.35M1.35M2.42M
Change in Accured Expenses (Quarter)
4.25M-15.62M65.99M8.20M26.16M3.39M-66.27M9.25M6.77M0.47M-2.99M-49.67M35.55M-76.68M-31.71M1.01M-17.45M-5.35M-2.45M6.49M
Other Working Capital Changes (Quarter)
0.50M6.29M0.46M-1.95M-6.78M8.00M-1.07M-3.13M31.59M0.77M-5.27M4.83M18.62M-19.19M-52.58M1.10M52.55M-0.17M-0.44M0.08M
Investing Activities
Capital Expenditures (Quarter)
1.57M1.40M1.64M0.91M0.86M-2.98M0.59M0.99M0.68M-2.17M0.03M0.01M0.08M0.14M0.02M0.01M0.01M
Sales of Property, Plant and Equipment (Quarter)
0.00M-0.00M0.84M0.21M
Acquisitions (Quarter)
Divestments (Quarter)
6.41M
Change in Acquisitions & Divestments (Quarter)
35.68M36.85M76.10M56.41M83.82M68.15M104.81M88.12M107.57M100.11M59.93M72.25M1.66M14.13M17.63M
Cash from Investing Activities (Quarter)
-122.15M-50.57M25.93M17.30M44.78M1.09M103.48M-14.29M54.22M10.24M51.28M72.24M0.76M1.72M-0.02M-0.01M87.16M-51.71M3.02M17.67M
Financing Activities
Other financing activities (Quarter)
49.75M30.75M17.66M0.05M
Cash from Financing Activities (Quarter)
-0.83M-0.03M-2.89M2.09M-1.09M48.67M31.48M91.53M-0.02M-0.25M-0.17M0.03M-0.13M0.01M-0.09M-0.01M-85.92M-0.01M-0.01M-0.01M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.11M0.84M0.18M2.60M0.21M1.20M0.91M17.30M0.04M0.12M0.02M
Additional items
Exchange Rate Effect (Quarter)
-0.10M2.25M0.11M-4.47M-3.61M2.49M-0.53M-2.64M-1.33M1.10M0.22M2.58M-1.96M-0.09M1.41M0.98M-1.26M-0.05M0.00M-0.03M
Change in Cash (Quarter)
-78.83M-103.30M14.67M-18.14M-11.80M-0.26M32.85M-35.97M-31.67M-7.23M-7.95M34.98M-9.71M-28.82M4.02M13.64M-1.87M32.08M-10.88M13.65M
Free Cash Flow (Quarter)
42.68M-56.36M-10.11M-33.97M-52.74M-49.53M-102.18M-111.56M-85.22M-16.16M-59.32M-39.88M-8.46M-30.61M2.70M12.67M-1.86M-18.33M-13.89M-3.99M
Net Cash Flow (Quarter)
-78.73M-105.56M14.57M-13.67M-8.19M-2.75M33.38M-33.32M-30.34M-8.32M-8.18M32.40M-7.75M-28.74M2.62M12.66M-0.60M-70.05M-10.88M13.68M